日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/05/07 | 7,260 | 7,420 | 7,240 | 7,260 | -70 | -1% | 189,800 |
| 2021/05/06 | 7,480 | 7,570 | 7,290 | 7,330 | -30 | -0.4% | 214,700 |
| 2021/04/30 | 7,260 | 7,450 | 7,230 | 7,360 | +100 | +1.4% | 148,700 |
| 2021/04/28 | 7,400 | 7,420 | 7,230 | 7,260 | -190 | -2.6% | 137,400 |
| 2021/04/27 | 7,570 | 7,580 | 7,410 | 7,450 | -80 | -1.1% | 119,100 |
| 2021/04/26 | 7,710 | 7,710 | 7,510 | 7,530 | -210 | -2.7% | 142,200 |
| 2021/04/23 | 7,790 | 7,850 | 7,730 | 7,740 | -170 | -2.1% | 117,400 |
| 2021/04/22 | 7,740 | 7,910 | 7,710 | 7,910 | +280 | +3.7% | 155,700 |
| 2021/04/21 | 7,690 | 7,730 | 7,600 | 7,630 | -140 | -1.8% | 108,800 |
| 2021/04/20 | 7,800 | 7,860 | 7,760 | 7,770 | -40 | -0.5% | 101,500 |
| 2021/04/19 | 7,830 | 7,930 | 7,790 | 7,810 | +50 | +0.6% | 76,400 |
| 2021/04/16 | 7,840 | 7,840 | 7,700 | 7,760 | -100 | -1.3% | 85,000 |
| 2021/04/15 | 7,750 | 7,860 | 7,750 | 7,860 | +130 | +1.7% | 62,600 |
| 2021/04/14 | 7,780 | 7,840 | 7,720 | 7,730 | -50 | -0.6% | 95,900 |
| 2021/04/13 | 7,820 | 7,910 | 7,770 | 7,780 | +50 | +0.6% | 67,100 |
| 2021/04/12 | 7,830 | 7,830 | 7,700 | 7,730 | -10 | -0.1% | 64,200 |
| 2021/04/09 | 7,690 | 7,850 | 7,670 | 7,740 | +60 | +0.8% | 111,700 |
| 2021/04/08 | 7,840 | 7,840 | 7,630 | 7,680 | -150 | -1.9% | 144,400 |
| 2021/04/07 | 7,930 | 7,930 | 7,790 | 7,830 | -110 | -1.4% | 170,200 |
| 2021/04/06 | 8,040 | 8,120 | 7,900 | 7,940 | -110 | -1.4% | 108,500 |
| 2021/04/05 | 8,180 | 8,190 | 8,040 | 8,050 | -70 | -0.9% | 100,600 |
| 2021/04/02 | 8,270 | 8,300 | 8,120 | 8,120 | -100 | -1.2% | 115,800 |
| 2021/04/01 | 8,320 | 8,340 | 8,190 | 8,220 | -10 | -0.1% | 202,900 |
| 2021/03/31 | 8,270 | 8,370 | 8,170 | 8,230 | -190 | -2.3% | 316,900 |
| 2021/03/30 | 8,470 | 8,470 | 8,280 | 8,420 | +50 | +0.6% | 218,500 |
| 2021/03/29 | 8,190 | 8,400 | 8,160 | 8,370 | +270 | +3.3% | 303,600 |
| 2021/03/26 | 7,910 | 8,130 | 7,860 | 8,100 | +190 | +2.4% | 157,500 |
| 2021/03/25 | 7,930 | 7,960 | 7,860 | 7,910 | +50 | +0.6% | 141,800 |
| 2021/03/24 | 7,950 | 7,960 | 7,800 | 7,860 | -130 | -1.6% | 139,900 |
| 2021/03/23 | 8,140 | 8,140 | 7,990 | 7,990 | -60 | -0.7% | 132,200 |
| 2021/03/22 | 7,980 | 8,070 | 7,920 | 8,050 | -10 | -0.1% | 133,900 |
| 2021/03/19 | 8,040 | 8,080 | 7,950 | 8,060 | +70 | +0.9% | 233,200 |
| 2021/03/18 | 8,030 | 8,040 | 7,880 | 7,990 | -60 | -0.7% | 222,600 |
| 2021/03/17 | 8,040 | 8,090 | 7,920 | 8,050 | -140 | -1.7% | 215,900 |
| 2021/03/16 | 8,170 | 8,220 | 8,110 | 8,190 | +80 | +1% | 170,700 |
| 2021/03/15 | 7,870 | 8,110 | 7,860 | 8,110 | +270 | +3.4% | 193,400 |
| 2021/03/12 | 7,780 | 7,840 | 7,700 | 7,840 | +110 | +1.4% | 195,100 |
| 2021/03/11 | 7,690 | 7,750 | 7,630 | 7,730 | +40 | +0.5% | 159,600 |
| 2021/03/10 | 7,710 | 7,730 | 7,650 | 7,690 | +60 | +0.8% | 165,000 |
| 2021/03/09 | 7,540 | 7,700 | 7,500 | 7,630 | +170 | +2.3% | 147,500 |
| 2021/03/08 | 7,440 | 7,550 | 7,420 | 7,460 | +130 | +1.8% | 180,500 |
| 2021/03/05 | 7,150 | 7,330 | 7,110 | 7,330 | +190 | +2.7% | 172,600 |
| 2021/03/04 | 7,190 | 7,210 | 7,060 | 7,140 | -180 | -2.5% | 171,800 |
| 2021/03/03 | 7,400 | 7,450 | 7,300 | 7,320 | -50 | -0.7% | 145,000 |
| 2021/03/02 | 7,380 | 7,410 | 7,290 | 7,370 | +40 | +0.5% | 166,300 |
| 2021/03/01 | 7,340 | 7,400 | 7,260 | 7,330 | +100 | +1.4% | 173,500 |
| 2021/02/26 | 7,530 | 7,530 | 7,220 | 7,230 | -330 | -4.4% | 259,000 |
| 2021/02/25 | 7,720 | 7,720 | 7,530 | 7,560 | -100 | -1.3% | 194,600 |
| 2021/02/24 | 7,840 | 7,850 | 7,650 | 7,660 | -150 | -1.9% | 187,900 |
| 2021/02/22 | 7,880 | 7,890 | 7,770 | 7,810 | +20 | +0.3% | 147,300 |
1001～
1050
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
